Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
EuropePMC; 2022.
Preprint in English | EuropePMC | ID: ppcovidwho-332576


Critical illness-associated cerebral microbleeds and leukoencephalopathy related to COVID-19 infection are increasingly being recognized in the literature. We report seven cases of COVID-19 with microbleeds in the juxtacortical white matter and corpus callosum and one case of leukoencephalopathy.

Journal of the American College of Cardiology (JACC) ; 79(9):3340-3340, 2022.
Article in English | Academic Search Complete | ID: covidwho-1749992
Travel Med Infect Dis ; 44: 102169, 2021.
Article in English | MEDLINE | ID: covidwho-1505906


BACKGROUND: /Aims: Corona virus disease 2019 (COVID 19) is a pandemic infectious disease of 2020, which often presents with respiratory and gastrointestinal symptoms. The behavior of the virus and its full clinical picture has not been fully studied yet. Many case reports and case series have been running in order to elaborate different presentations and associations. Pulmonary and gastrointestinal features of COVID-19 infection are well outlined; however, neurological manifestations are less defined. CASE PRESENTATION: We report two adult cases of COVID-19 infection presented with acute Guillain-Barre Syndrome (GBS), and a literature review on the causal association between COVID-19 and GBS. CONCLUSION: Our two case reports in addition to literature review of 116 published cases may help offer insight into the clinical course of COVID-19 infection. Our two COVID-19 patients presented with neurological manifestations of GBS which were not preceded with any respiratory, gastrointestinal or other systemic infection. This leads us to raise the possibility of establish direct causal association between COVID-19 infection and GBS. Physicians should have high clinical suspicions when encounter GBS patient during the current COVID-19 pandemic and consider co-existence of COVID-19 infection that may warrant SARS-CoV-2 testing, isolation precautions, and specific treatment for Covid-19 infection.

COVID-19 , Guillain-Barre Syndrome , Adult , COVID-19 Testing , Guillain-Barre Syndrome/diagnosis , Guillain-Barre Syndrome/epidemiology , Humans , Pandemics , SARS-CoV-2
SAGE Open Med Case Rep ; 9: 2050313X20983211, 2021.
Article in English | MEDLINE | ID: covidwho-1105592


COVID-19 is an infectious disease, which often presents with fever and respiratory symptoms. However, gastrointestinal symptoms have also been reported to occur in patients with COVID-19. Although abdominal pain was described in some reports of COVID-19, it was uncommon and often associated with other symptoms. We describe a challenging case of a COVID-19 patient who presented with severe isolated abdominal pain initially, then developed pneumonia symptoms which led to the diagnosis of COVID-19 thereafter.